DE59911381D1 - Verwendung von testosteronestern und/oder testosteron zur herstellung von bukkal applizierbaren bioadhasiven systemen mit zeitgesteuerter arzneistoffwirkung - Google Patents

Verwendung von testosteronestern und/oder testosteron zur herstellung von bukkal applizierbaren bioadhasiven systemen mit zeitgesteuerter arzneistoffwirkung

Info

Publication number
DE59911381D1
DE59911381D1 DE59911381T DE59911381T DE59911381D1 DE 59911381 D1 DE59911381 D1 DE 59911381D1 DE 59911381 T DE59911381 T DE 59911381T DE 59911381 T DE59911381 T DE 59911381T DE 59911381 D1 DE59911381 D1 DE 59911381D1
Authority
DE
Germany
Prior art keywords
testosterone
systems
testostereses
bukkal
bioadhasive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59911381T
Other languages
English (en)
Inventor
Doris Huebler
Guenter Kaufmann
Michael Oettel
Holger Zimmermann
Michael Dittgen
Sabine Fricke
Manfred Boese
Ralf Ladwig
Sven Claussen
Carsten Timpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority claimed from PCT/EP1999/007254 external-priority patent/WO2000019975A1/de
Application granted granted Critical
Publication of DE59911381D1 publication Critical patent/DE59911381D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE59911381T 1998-10-02 1999-09-30 Verwendung von testosteronestern und/oder testosteron zur herstellung von bukkal applizierbaren bioadhasiven systemen mit zeitgesteuerter arzneistoffwirkung Expired - Fee Related DE59911381D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19847252A DE19847252B4 (de) 1998-10-02 1998-10-02 Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
PCT/EP1999/007254 WO2000019975A1 (de) 1998-10-02 1999-09-30 Verwendung von testosteronestern und/oder testosteron zur herstellung von bukkal applizierbaren bioadhäsiven systemen mit zeitgesteuerter arzneistoffwirkung

Publications (1)

Publication Number Publication Date
DE59911381D1 true DE59911381D1 (de) 2005-02-03

Family

ID=7884375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19847252A Expired - Lifetime DE19847252B4 (de) 1998-10-02 1998-10-02 Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
DE59911381T Expired - Fee Related DE59911381D1 (de) 1998-10-02 1999-09-30 Verwendung von testosteronestern und/oder testosteron zur herstellung von bukkal applizierbaren bioadhasiven systemen mit zeitgesteuerter arzneistoffwirkung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19847252A Expired - Lifetime DE19847252B4 (de) 1998-10-02 1998-10-02 Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron

Country Status (3)

Country Link
AT (1) ATE285750T1 (de)
DE (2) DE19847252B4 (de)
ES (1) ES2235523T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043434A1 (en) * 2002-11-14 2004-05-27 Shear/Kershman Laboratories, Inc. Oral testosterone delivery system with improved sustained release
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
WO1991006289A1 (en) * 1989-10-31 1991-05-16 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
CA2197327A1 (en) * 1994-09-30 1996-04-11 Shigeyuki Takada Oral sustained-release preparation
AUPM855194A0 (en) * 1994-10-04 1994-10-27 Csl Limited Controlled-release pharmaceutical preparations

Also Published As

Publication number Publication date
DE19847252B4 (de) 2004-02-12
ES2235523T3 (es) 2005-07-01
DE19847252A1 (de) 2000-04-13
ATE285750T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
NO991342L (no) Anvendelse av fumarsyrederivater ved behandling av autoimmune sykdommer
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
ATE367087T1 (de) Formulierungen zur behandlung von krankheiten und verfahren unter deren verwendung
AR002254A1 (es) Formulacion antitrombotica y procedimiento para su manufactura
ATE151282T1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
ATE311201T1 (de) Testosteron-ester formulierung zur anwendung am menschen
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
NO940035D0 (no) Kolesterolester, samt anvendelse av slike estere
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69934813D1 (de) Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen
FI950909A (fi) Rasvahappojohdannaisia
CA2216887A1 (en) Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases
ATE353671T1 (de) Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz,zur behandlung und reparation von bindegeweben in menschen und tieren
HUP0100066A2 (hu) Egy diol és egy alfa-hidroxisav keverékének alkalmazása hiperkeratózisos bőrbetegségek kezelésére
NO20006506D0 (no) Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
DE59911381D1 (de) Verwendung von testosteronestern und/oder testosteron zur herstellung von bukkal applizierbaren bioadhasiven systemen mit zeitgesteuerter arzneistoffwirkung
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
DE59603130D1 (de) Verwendung von Steroiden mit antioxidativen Eigenschaften zur Herstellung von pharmazeutischen Präparaten zur medikamentösen Substitution beim Mann
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
DE69808663T2 (de) Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
ID16678A (id) Penggunaan asam fosforik ester untuk pengobatan fungsi penyakit-penyakit pada otak dan depresi
WO1999016429A3 (en) Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases
GEP19971090B (en) Plaster “Fagodermi“

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE

8339 Ceased/non-payment of the annual fee